Project Number 5R01AG060987-02 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Treating hyperexcitability in Alzheimer?s disease with levetiracetam to improve brain function and cognition Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator SHAFI, MOUHSIN Principal Investigator First Name MOUHSIN Principal Investigator Last Name SHAFI Awardee Organization BETH ISRAEL DEACONESS MEDICAL CENTER Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-175: Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $584,852 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
